BancST 202 1

Clinical Trials

At ITRT, we are leading the clinical research worldwide in Regenerative Therapy, proving the unprecedented efficacy and safety of Cultured Mesenchymal Stem Cells in diverse pathologies.
Our 22 clinical trials are the world’s largest body of scientific evidence on regeneration, reason why we have been quoted more than 1,800 times in the most prestigious medical and scientific journals.

The numerous clinical trials carried out since 2003 have shown unprecedented results that scientifically prove that thanks to the volume of millions of cells we apply,

it is possible to regenerate tissues that until now were considered unviable.

Completed clinical trials

with Cultured Mesenchymal Stem Cells

Ongoing clinical trials

with Cultured Mesenchymal Stem Cells

Platelet-Rich Plasma (PRP)

Pre-Clinical Trials

The trials that ITRT has conducted to treat pathologies from the musculoskeletal system in animals, have been the basis for the research on the efficacy and safety of Cultured Stem Cell therapy in diverse pathologies.

Foto 2 Lab Banc Sang Teixits

Completed Trials

with Cultured Mesenchymal Stem Cells

Completed Trials

with Platelet-Rich Plasma (PRP)




The scientific journal “Integrative Clinical Medicine” has published the feature “Treatment with mesenchymal stem cells for xerostomia: A…

Presentation in Costa Rica

On August 7, Dr. Robert Soler Rich, Medical Director of the ITRT, gave the presentation “Treatment with cultured…

ITRT proves for the first time that tendon can be regenerated with cultured mesenchymal stem cells

Data from the clinical trial, which has just been published in the prestigious American Journal of Sports Medicine,…